Product References — human elisa

The Impact of Age and BMI on the VWF/ADAMTS13 Axis and Simultaneous Thrombin and Plasmin Generation in Hospitalized COVID-19 Patients

Posted by Adam Awdish on

The Impact of Age and BMI on the VWF/ADAMTS13 Axis and Simultaneous Thrombin and Plasmin Generation in Hospitalized COVID-19 Patients

Human Total Factor VIII ELISA Kit from Innovative Research was used in the following study:   The Impact of Age and BMI on the VWF/ADAMTS13 Axis and Simultaneous Thrombin and Plasmin Generation in Hospitalized COVID-19 Patients Kiruphagaran Thangaraju, Upendra Katneni, Imo J. Akpan, Kenichi Tanaka, Tiffany Thomas, Saini Setua, Julie A. Reisz, Francesca Cendali, Fabia Gamboni, Travis Nemkov, Stacie Kahn, Alexander Z. Wei, Jacob E. Valk, Krystalyn E. Hudson, David J. Roh, Chiara Moriconi, James C. Zimring, Angelo D'Alessandro, Steven L. Spitalnik, Richard O. Francis, and Paul W. Buehler Frontiers in Medicine January 10, 2022 COVID-19 infection results in a...

Read more →

Stability of Alteplase for Ultrasound-Facilitated Catheter-Directed Thrombolysis

Posted by Adam Awdish on

Stability of Alteplase for Ultrasound-Facilitated Catheter-Directed Thrombolysis

Human tPA ELISA Kit from Innovative Research was used in the following study:   Stability of Alteplase for Ultrasound-Facilitated Catheter-Directed Thrombolysis John Fanikos, Kathleen Marquis, Leo Buckley, Lena K. Tran, Kevin McLaughlin, Abby Jane Golash, Umberto Campia, Gregory Piazza, Jean M. Connors, Samuel Z. Goldhaber Blood Advances December 8, 2021 Ultrasound-facilitated catheter-directed thrombolysis (USCDT) is a form of treatment for pulmonary embolism that may minimize the effects of major bleeding complications during treatment. USCDT typically uses low-dose alteplase over the course of up to 8 hours, as major bleeding complications usually result from the administration of high doses of alteplase...

Read more →

×